NovaBay Pharmaceuticals to Hold First Quarter 2018 Conference Call on May 10, 2018

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing its prescription Avenova® lid and lash hygiene product for the domestic eye care market, announces that it will report first quarter 2018 financial results after market close on Thursday, May 10. Management will hold an investment community conference call that day to discuss financial results and provide a Company update. DATE:                 Thursd

Full Story →